Report: Britain to roll out AstraZeneca vaccine on January 4

British Government urged to accelerate vaccination efforts as new strain of COVID-19 continues to spread.

Arutz Sheva Staff ,


The coronavirus vaccine developed by AstraZeneca and Oxford University will be rolled out in Britain starting January 4, The Telegraph newspaper reported Saturday.

The Government is aiming for two million people to receive their first dose of either the Oxford vaccine or the Pfizer vaccine within a fortnight as part of a major ramping up of the inoculation program, according to the report.

Mass vaccination centers at sports stadiums and conference venues are primed to launch in the second week of January, provided the regulator approves the Oxford-AstraZeneca vaccine within days, the newspaper said.

The rollout of the Oxford vaccine, which is easier to store and handle than the Pfizer jab and costs less, is likely to make it easier to reach people living in the most secluded areas of England.

The Government has ordered 100 million doses, with 40 million due to be rolled out by March next year. Senior Government sources said that approval could come as soon as Sunday.

On Saturday night, the chief executive of AstraZeneca said that its vaccine is as effective as the ones developed by Pfizer and Moderna.

Britain began its vaccination campaign earlier this month, administering doses of the Pfizer vaccine.

Saturday’s report comes amid growing pressure on the British Government to accelerate the rollout of the vaccine in response to surging infection rates across the country, fuelled by the new strain of COVID-19 which is believed to have originated in Kent.

Last week, Britain announced a stay at home order for part of the country to slow the new variant.